Results from these three independent studies demonstrated that high ALDH1A1 gene expression level is associated with reduced breast cancer recurrence and total mortality in patients with TNBC, independent of age at diagnosis and TNM stage. This evidence concerns the gene ALDH1A1 and breast carcinoma.